Reference health
A Low-Intensity Repetitive Transcranial Magnetic Stimulation Coupled to Magnetic Nanoparticles Loaded with Scutellarin Enhances Brain Protection Against Cerebral Ischemia Reperfusion Injury
52/52 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
15 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 52 checked references that resolve
resolves10.1136/svn-2020-000529
China Stroke Statistics 2019: a wealth of opportunities for stroke prevention
resolves10.1016/j.expneurol.2020.113518
Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies
resolves10.4103/bc.bc_36_18
Treatment for ischemic stroke: From thrombolysis to thrombectomy and remaining challenges
resolves10.1161/STROKEAHA.120.032810
Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke
resolves10.1016/j.rehab.2015.05.005
Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS)
resolves10.3390/brainsci11030384
Probing the Brain–Body Connection Using Transcranial Magnetic Stimulation (TMS): Validating a Promising Tool to Provide Biomarkers of Neuroplasticity and Central Nervous System Function
resolves10.1016/j.clinph.2019.11.002
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)
resolves10.1016/j.neurol.2021.07.004
French guidelines for neuropathic pain: An update and commentary
resolves10.1177/1756286419878317
Repetitive transcranial magnetic stimulation in stroke rehabilitation: review of the current evidence and pitfalls
resolves10.1016/j.clinph.2020.10.003
Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines
resolves10.1111/ner.12946
Safety, Tolerability, and Nocebo Phenomena During Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis of Placebo-Controlled Clinical Trials
resolves10.2147/NDT.S276635
<p>Transcranial Magnetic Stimulation (TMS) Safety with Respect to Seizures: A Literature Review</p>
resolves10.1016/j.ejmech.2010.01.006
PEG-scutellarin prodrugs: Synthesis, water solubility and protective effect on cerebral ischemia/reperfusion injury
resolves10.1016/j.ijpharm.2014.09.038
Sustained release and enhanced bioavailability of injectable scutellarin-loaded bovine serum albumin nanoparticles
resolves10.1208/s12249-014-0080-4
Mixed Polyethylene Glycol-Modified Breviscapine-Loaded Solid Lipid Nanoparticles for Improved Brain Bioavailability: Preparation, Characterization, and In Vivo Cerebral Microdialysis Evaluation in Adult Sprague Dawley Rats
resolves10.1021/acs.molpharmaceut.1c00942
Intravenous Administration of Scutellarin Nanoparticles Augments the Protective Effect against Cerebral Ischemia–Reperfusion Injury in Rats
resolves10.1002/biot.201700203
Tuning the Size of Poly(lactic‐co‐glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation
resolves10.3390/polym10060579
Novel PEG-Modified Hybrid PLGA-Vegetable Oils Nanostructured Carriers for Improving Performances of Indomethacin Delivery
resolves10.1161/01.STR.20.1.84
Reversible middle cerebral artery occlusion without craniectomy in rats.
resolves10.3389/fnins.2021.772401
Total Flavonoids of Chuju Decrease Oxidative Stress and Cell Apoptosis in Ischemic Stroke Rats: Network and Experimental Analyses
resolves10.1002/jbm.b.33648
Polymer degradation and drug delivery in <scp>PLGA</scp>‐based drug–polymer applications: A review of experiments and theories
resolves10.3390/polym3031377
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
resolves10.1016/j.jconrel.2021.01.038
Controlled drug release: On the evolution of physically entrapped drug inside the electrospun poly(lactic-co-glycolic acid) matrix
resolves10.1016/j.colsurfb.2018.10.051
Recent advances in magnetic fluid hyperthermia for cancer therapy
resolves10.3390/molecules25122874
Magnetic Hyperthermia for Cancer Treatment: Main Parameters Affecting the Outcome of In Vitro and In Vivo Studies
resolves10.1039/D1CS00427A
Magnetic nanoparticles and clusters for magnetic hyperthermia: optimizing their heat performance and developing combinatorial therapies to tackle cancer
resolves10.7150/thno.40858
Using magnetic particle imaging systems to localize and guide magnetic hyperthermia treatment: tracers, hardware, and future medical applications
resolves10.1080/02656736.2021.2023225
Exposure to acute noxious heat evokes a cardiorespiratory shock response in humans
resolves10.1142/S0192415X18500167
Pharmacological Effects of Scutellarin, An Active Component of Genus<i>Scutellaria</i>and<i>Erigeron</i>: A Systematic Review
resolves10.1016/j.jconrel.2016.05.044
Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases
resolves10.1097/WNR.0000000000001706
Neurovascular protection of salvianolic acid B and ginsenoside Rg1 combination against acute ischemic stroke in rats
resolves10.1016/j.jstrokecerebrovasdis.2017.09.008
The Use of Repetitive Transcranial Magnetic Stimulation for Stroke Rehabilitation: A Systematic Review
resolves10.1016/j.apmr.2013.10.023
Efficacy of Coupling Repetitive Transcranial Magnetic Stimulation and Physical Therapy to Reduce Upper-Limb Spasticity in Patients With Stroke: A Randomized Controlled Trial
resolves10.1016/0168-5597(94)90124-4
Finding the depth of magnetic brain stimulation: a re-evaluation
resolves10.1109/TBME.2005.862545
Suppressing the Surface Field During Transcranial Magnetic Stimulation
resolves10.1111/ejn.15195
Selecting stimulation intensity in repetitive transcranial magnetic stimulation studies: A systematic review between 1991 and 2020
resolves10.1016/j.pharmthera.2018.05.006
Clinical benefits and pharmacology of scutellarin: A comprehensive review
resolves10.1007/s11655-020-2716-4
Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach
resolves10.1067/mhj.2001.118113
Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease
resolves10.2217/pgs-2018-0098
Pharmacogenetic Relevance of Endothelial Nitric Oxide Synthase Polymorphisms and Gene Interactions
resolves10.1016/j.addr.2019.01.005
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
resolves10.1016/j.neuron.2014.03.003
Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in Stroke
resolves10.3171/foc.2007.22.5.5
Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia
resolves10.1021/acsnano.9b01808
Selective Liposomal Transport through Blood Brain Barrier Disruption in Ischemic Stroke Reveals Two Distinct Therapeutic Opportunities
resolves10.1016/j.bbrc.2010.04.154
Magnetic fields at extremely low-frequency (50Hz, 0.8mT) can induce the uptake of intracellular calcium levels in osteoblasts
resolves10.1016/j.brs.2014.09.012
Cellular and Molecular Changes to Cortical Neurons Following Low Intensity Repetitive Magnetic Stimulation at Different Frequencies
The 15 references without a DOI — listed, not checked
no DOI — not checkedref2
no DOI — not checkedref3
no DOI — not checkedref4
no DOI — not checkedref14
no DOI — not checkedStudy on the neuroprotective effect of scutellarin based on rat middle cerebral artery occlusion model
no DOI — not checkedIntraluminal middle cerebral artery occlusion (MCAO) model for ischemic stroke with laser doppler flowmetry guidance in mice
no DOI — not checkedA UPLC-ESI-MS/MS method for simultaneous quantitation of chlorogenic Acid, scutellarin, and scutellarein in rat plasma: application to a comparative pharmacokinetic study in sham-operated and MCAO rats after oral administration of Erigeron breviscapus extract
no DOI — not checkedref29
no DOI — not checkedA comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles
no DOI — not checkedTherapeutic effects of breviscapine in cardiovascular diseases: a review
no DOI — not checkedref44
no DOI — not checkedStructure of coagulation factor ?:molecular mechanism of thrombin generation and development of next-generation anticoagulants
no DOI — not checkedNeuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion
no DOI — not checkedProtective mechanism of Erigeron breviscapus injection on blood-brain barrier injury induced by cerebral ischemia in rats
no DOI — not checkedref63
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.4147099"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4147099/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.4147099)